CRITERIA USED BY GERMAN PULMONOLOGISTS FOR THE SELECTION OF AN INHALER

Author(s)

Schwarz E¹, Redeker M¹, Mohrlang C¹, Andres J², Hellmann A³, Hering T⁴, Hering T²
¹GlaxoSmithKline GmbH & Co. KG, München, Germany, ²Wissenschaftliches Netzwerk des Bundesverbandes der Pneumologen/BdP (WinPneu), Heidenheim, Germany, ³Zentrum für Pneumologie, Onkologie und Schlafmedizin am Diako, Augsburg, Germany, ⁴Lungenarztpraxis Tegel, Berlin, Germany

Presentation Documents

PMD107--strong-u-schwarz-e-u-sup-1-sup-strong-redeker-m-sup-1-sup-mohrlang-c-sup-1-sup-andres-j-sup-2-sup-hellmann-a-sup-3-sup-hering-t-sup-4-sup-hering-t-sup-2-sup-br-sup-1-sup-glaxosmithkline-gmbh-co-kg-munchen-germany-sup-2-sup-wissensch ...

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PMD107

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care

Topic Subcategory

Health Care Research, Pricing Policy & Schemes

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic

Presentation